Yonghui Wu Kai Zhang Jiexia Guan Weibin Wu Jian Zhang Huiguo Chen
10.2147/CMAR.S326094
Cancer Manag Res
2021 Sep 9;13:7047-7053.
egfr mutation pik3ca mutation adenosquamous carcinoma anlotinib resistant mutation
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/34526820/
Case Reports
PMC8437381
34526820
Treatment with Anlotinib After Chemotherapy and EGFR-TKI Resistance in Lung Adenosquamous Carcinoma with Concurrent EGFR and PIK3CA Mutations: A Case Report and Literature Review
2021